Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Huvudupphovsman: | Karim, Samia Binte |
---|---|
Övriga upphovsmän: | Azam, Faruque |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
Brac University
2024
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/23944 |
Liknande verk
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
av: Hoque, Ismoth Ara
Publicerad: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
av: Paul, Pulock
Publicerad: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
av: Rahman, Tasnim
Publicerad: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Flora, Sanzida Alam
Publicerad: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
av: Hasan, Sakib
Publicerad: (2024)